ArticlePathology oncology research : POR2021

The Impact of IDH1 Mutation and MGMT Promoter Methylation on Recurrence-Free Interval in Glioblastoma Patients Treated With Radiotherapy and Chemotherapeutic Agents.

Maher Kurdi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.